ライフサイエンスコーパス: parenteral administration

1 ssing a current need for alternatives to ICG parenteral administration.

2 FpEF, but its use is limited by the need for parenteral administration.

3 f less than 100nm are excellently suited for parenteral administration.

4 ltiple sclerosis and rheumatoid arthritis by parenteral administration.

5 duce recombinant pharmaceutical proteins for parenteral administration.

6 alf-life, necessitating frequent, continuous parenteral administration.

7 ing in a PK profile suitable for long-acting parenteral administration.

8 ific drug delivery and medical imaging after parenteral administration.

9 ut until recently it has required cumbersome parenteral administration.

10 al conditions that require frequent, chronic parenteral administration.

11 us oocytes and were convulsant in mice after parenteral administration.

12 and poor patient convenience as they require parenteral administration.

13 ble antibody therapies must be delivered via parenteral administration.

14 ely suited for controlled drug delivery with parenteral administration.

15 ing a variety of therapeutics formulated for parenteral administration.

16 ptide and protein drugs, although limited to parenteral administration.

17 trategy to increase solubility and allow for parenteral administration.

18 gh costs, safety risks, and the necessity of parenteral administration.

19 enstrom's macroglobulinemia (WM) but require parenteral administration and are associated with polyne

20 a Molina tree has been proved to be safe for parenteral administration and represents a potential alt

21 ncerns about its cost, the need for frequent parenteral administration, and the development of anti-E

22 qualitatively similar to that induced by VLP parenteral administration, and this response was enhance

23 sible particles in formulations intended for parenteral administration are of concern in the biopharm

24 ral drugs (ARVs) were recently developed for parenteral administration at monthly or longer intervals

25 more polar molecules that currently require parenteral administration because the vaginal epithelium

26 rising fewer injections and oral rather than parenteral administration, compared with a reference tre

27 The definition of resistance for parenteral administration does not apply to inhaled tobr

28 h oral administration and always <50 nM with parenteral administration, even when corresponding ascor

29 ls to serve as a satisfactory alternative to parenteral administration for the treatment of severe an

30 As an alternative to repetitive parenteral administration, gene therapy may provide a no

31 ration of rotavirus vaccine for live oral or parenteral administration.IMPORTANCE Mechanisms for in v

32 lation reduced palbociclib toxicity, enabled parenteral administration, improved CNS pharmacokinetics

33 sc versus po also underscores the idea that parenteral administration is a reasonable alternative to

34 for patients, since repetitive and long-term parenteral administration is required as most proteins a

35 r specificity and affinity, the conventional parenteral administration is suboptimal in delivering an

36 Parenteral administration of 2.2 g/kg glucose solution i

37 cumulation in cells is the topical, oral, or parenteral administration of 5-aminolevulinic acid, a pr

38 In a streptomycin-treated mouse model, parenteral administration of 5C12 significantly protecte

39 Parenteral administration of 6-OHDA to mice resulted in

40 Parenteral administration of a mouse anti-human CD8 mono

41 Taken together, these data suggest parenteral administration of adjuvanted, inactivated who

42 Topical and parenteral administration of an IgA monoclonal antibody

43 We used parenteral administration of antalarmin, a novel, small

44 teractions in tumors and normal tissue after parenteral administration of antitumor antibodies to hum

45 extracellular fluid was detected only after parenteral administration of ascorbate and when Asc(*-)

46 Parenteral administration of CD3-specific monoclonal ant

47 elling than reported selection in vivo after parenteral administration of ceftiofur.

48 Parenteral administration of CRH, however, results in hy

49 Parenteral administration of either native or recombinan

50 Neutralization of macaque IL-15 by parenteral administration of Hu714MuXHu reduces (>95%) c

51 Parenteral administration of IL-4 resulted in augmented

52 We have compared mucosal versus traditional parenteral administration of inactivated influenza vacci

53 Parenteral administration of iron produced increased iro

54 on absorption by activation of HIF-2alpha or parenteral administration of iron-dextran in HIF-2alpha

55 Parenteral administration of lipopolysaccharide 2-24 hou

56 Parenteral administration of lipopolysaccharide resulted

57 Finally, parenteral administration of MBL increased resistance of

58 its immunogenicity and also that mucosal or parenteral administration of microspheric formulations o

59 miliar arena or high light, familiar arena), parenteral administration of nicotine had bimodal action

60 Parenteral administration of platelet glycoprotein IIb/I

61 Parenteral administration of precise doses of omega-3 fa

62 in all subjects, these results of the first parenteral administration of rAAV demonstrate that admin

63 Parenteral administration of recombinant human erythropo

64 een postulated as a potential alternative to parenteral administration of recombinant proteins.

65 Although parenteral administration of sufficient RSV-specific IgG

66 Here we show that long-term parenteral administration of superphysiological doses of

67 Collectively, these findings indicate that parenteral administration of the antioxidant ALA signifi

68 ioavailability issues related to the desired parenteral administration of the chosen clinical candida

69 ency disease (SCID) mice were transfected by parenteral administration of the vector.

70 In rats, parenteral administration of the water-soluble glipizide

71 ease may be transmitted by oral ingestion or parenteral administration of these conformationally alte

72 ated from blood rapidly via the stools after parenteral administration of thiomersal in vaccines.

73 d coverage of four childbirth interventions (parenteral administration of uterotonics, antibiotics, a

74 Parenteral administration schedules have been evaluated

75 Furthermore, after parenteral administration, the FhHDM-1 peptide interacte

76 whereas liposomal AMB is costly and requires parenteral administration, thus development of novel for

77 with the following different adjuvants after parenteral administration to mice: alum, a derivative of

78 ohol-maintained responding after central and parenteral administrations, together with its low-effica